JFGLC
SCPH

Johnson Financial Group LLC (Colorado)’s scPharmaceuticals SCPH Stock Holding History

Johnson Financial Group LLC (Colorado)’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-85,184
Closed -$224K – 101
2025
Q1 		$224K Hold
85,184
– – 0.02% 89
2024
Q4 		$302K Buy
+85,184
New +$326K 0.04% 41

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Johnson Financial Group LLC (Colorado)'s SCPH Position: Q2 2025 in Review

Johnson Financial Group LLC (Colorado) sold out of scPharmaceuticals (SCPH) in Q2 2025, closing a stake of 85,184 shares — an estimated $224K sold.

Johnson Financial Group LLC (Colorado) first reported a position in SCPH in Q4 2024 and held it in 2 quarters. The position peaked at $302K in Q4 2024. 97 funds tracked by Wall St. Rank hold SCPH as of Q2 2025.

  • Johnson Financial Group LLC (Colorado) reported no remaining scPharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Johnson Financial Group LLC (Colorado) sold 85,184 scPharmaceuticals shares in Q2 2025, an estimated $224K.
  • Johnson Financial Group LLC (Colorado) first reported a position in scPharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Johnson Financial Group LLC (Colorado)'s scPharmaceuticals position peaked at $302K in Q4 2024.
  • 97 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2025.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q2 2025, filed 11 Aug 2025.